Todd Young serves as the Executive Vice President and Chief Financial Officer at Elanco Animal Health Inc., a global leader in animal health products and services. With a robust background in finance and strategic management, Young has been instrumental in driving Elanco's financial performance and strategic initiatives. Before joining Elanco in 2015, he held significant roles at Eli Lilly and Company, where he gained extensive experience in financial planning, analysis, and corporate strategy. His career at Eli Lilly included positions such as finance director for global manufacturing and senior director of finance for the company's animal health division, which provided a solid foundation for his transition to Elanco. At Elanco, Todd Young has been pivotal in steering the company through its spin-off from Eli Lilly in 2018, ensuring a smooth transition and establishing a strong financial framework for the newly independent entity. Under his leadership, Elanco has pursued aggressive growth strategies, including key acquisitions that have expanded the company's portfolio and market reach. Young's strategic foresight and financial acumen have been crucial in navigating the complexities of the animal health industry, enabling Elanco to achieve sustained revenue growth and profitability. His role encompasses overseeing all aspects of the company's financial operations, from budgeting and forecasting to investor relations, making him a key figure in Elanco's ongoing success and future expansion plans.